Back to top

AstraZeneca and MedImmune in Cambridge

The best science doesn’t happen in isolation – it takes collaboration. That’s why we are building our new global research and development headquarters in the heart of the Cambridge Biomedical Campus. 

See jobs
Cambridge is a unique and beautiful city, renowned for its world-class university and the thriving cluster of high technology businesses that have grown up around it. In fact, in 2016, it was crowned the best UK city to work in according to job and recruiting website Glassdoor. The city is Cambridge is home to more than 4,300 knowledge-based companies employing more than 58,000 people. Just 50 miles from London, the city is well served by road and rail links, and is within easy distance of the major London airports.

City House, AstraZeneca

Along with Academy House in Cambridge city centre, our temporary location at City House provides space for colleagues from Global Medicines Development, Global Product and Portfolio Strategy and enabling units.

Academy House, AstraZeneca

Along with City House in Cambridge city centre, Academy House provides space for colleagues from Global Medicines Development, Global Product and Portfolio Strategy and enabling units.

Co-located with Cancer Research UK, AstraZeneca

Temporarily co-located with Cancer Reasearch UK, around 60 colleagues from our Oncology team will be based here.

MRC Laboratory of Molecular Biology

The MRC Laboratory of Molecular Biology is one of the world's leading research institutes. Scientists at this location are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

The Forum

A new and improved post-graduate education centre, The Forum will include a 550-seat conference centre, 75-bed private hospital, and hotel with around 200 rooms to serve Cambridge Biomedical Campus users. It will also comprise a range of shops, restaurants and a 470-space car park.

The project is entirely privately funded with all financial benefits going towards NHS patient care.

Global R&D Centre and Corporate Headquarters, AstraZeneca

The Cambridge site will become our largest centre for oncology research worldwide. Beyond cancer research, our R&D will focus on cardiovascular and metabolic diseases, respiratory, inflammation and autoimmune diseases and conditions of the central nervous system. The site will bring together our small molecule and biologics R&D, opening up opportunities to exploit the promise of small and large molecule combinations.

Additionally, we will have medicinal chemistry, high-throughput screening and cellular and molecular biology, as well as clinical development and pre-clinical research capabilities located on the site.

Barbraham Research Campus, AstraZeneca

The Babraham Institute is one of three world-leading biomedical research institutions in Cambridge that works in a strategic alliance with AstraZeneca, to advance cancer research and develop and evaluate new therapeutic strategies to tackle prostate and pancreatic cancers. Other projects between the partners will study cancer tumour mutations and aim to better understand how the genetic makeup of an individual patient’s cancer determines their response to treatment.

The Da Vinci Building, AstraZeneca

As the new temporary headquarters for AstraZeneca in Cambridge, The da Vinci building in Melbourn Science Park is the workplace for nearly 400 members of staff from our R&D teams, Global Product and Portfolio Strategy and enabling teams.

Designed to be a flexible working environment, large open workspaces inpire collaboration and innovation and make da vinci a great workspace

Chesterford Research Park, AstraZeneca

Another of our temporary offices, located on Chesterfield Research Park, this work space provides lab and office facilities for scientists from our oncology and personalised healthcare teams from our IMED Biotech Unit.

Darwin Building, AstraZeneca

The Darwin Building provides temporary lab and office facilities within the Cambridge Science Park and is home to teams from across our IMED Biotech unit.

Granta Building, AstraZeneca and MedImmune

Home to collegues from MedImmune and housing approximately 500 people. MedImmune is known as a world-leader in protein engineering and biologics drug development.

Permanent location Temporary location

Academy House, AstraZeneca

Granta Park, AstraZeneca and MedImmune

Chesterford Research Park, AstraZeneca

Co-located with Cancer Research UK, AstraZeneca

Global R&D Centre and Corporate Headquarters, AstraZeneca

Why did AstraZeneca choose Cambridge for its Global Headquarters

The Cambridge Biomedical Campus (CBC) is globally renowned as a leading centre of research, education and patient care. For AstraZeneca, the campus is the perfect environment in which to foster a vibrant culture of open innovation and collaboration. We believe that our arrival will encourage an even greater spirit of sharing, bold thinking and pioneering exciting, new science.

AstraZeneca Global R&D Centre and Corporate HQ

AstraZeneca Global R&D Centre and Corporate HQ

The Cambridge site will become our largest centre for oncology research worldwide. Beyond cancer research, our R&D will focus on cardiovascular and metabolic diseases, respiratory, inflammation and autoimmune diseases and conditions of the central nervous system. The site will bring together our small molecule and biologics R&D, opening up opportunities to exploit the promise of small and large molecule combinations.

Additionally, we will have medicinal chemistry, high-throughput screening and cellular and molecular biology, as well as clinical development and pre-clinical research capabilities located on the site.

The Forum

The Forum

A new and improved post-graduate education centre, The Forum will include a 550-seat conference centre, 75-bed private hospital, and hotel with around 200 rooms to serve Cambridge Biomedical Campus users. It will also comprise a range of shops, restaurants and a 470-space car park.

The project is entirely privately funded with all financial benefits going towards NHS patient care.

New Papworth Hospital

New Papworth Hospital

The largest specialist cardiothoracic hospital in the UK, Papworth is also home to the country's main heart and lung transplant centre. It’s performed the highest number of heart surgery procedures over the past three years while achieving the UK’s lowest cardiac surgery mortality rate. Papworth prides itself on the highest levels of clinical quality and providing exceptional standards of personalised care.

Over 24,400 patients are treated and 73,600 outpatients are seen each year from across the UK. The hospital’s services are internationally recognised and include cardiology, respiratory medicine, sleep medicine, cardiac surgery, thoracic surgery and heart & lung transplantation.

Heart and Lung Institute

Heart and Lung Institute

The Heart and Lung Institute focuses on research into respiratory disease. Housing world-class groups investigating respiratory infections, cell and leukocyte biology, airways and allergic diseases, integrative physiology and pharmacology, public health and genetics and genomics.

Future development for Cambridge University Hospitals

Future development for Cambridge University Hospitals

Over the next few years, the facilities for research on the Biomedical Campus will be greatly increased as more organisations join.

Future development for Cambridge University Hospitals

Future development for Cambridge University Hospitals

Over the next few years, the facilities for research on the Biomedical Campus will be greatly increased as more organisations join.

Proposed energy centre by Cambridge University Hospitals

Proposed energy centre by Cambridge University Hospitals

The Energy Centre will be part of the Cambridge Biomedical Campus. Its aim will be to cut carbon emissions by around 50% and help the Trust to surpass its NHS sustainability targets. The centre’s distinctive design reflects its location on the masterplan, together with its internal functions. Its form is inspired by the melding of these two factors. The orthogonal planning with the north-south roof orientation will optimise the potential for voltaic panels.

Corrugated panels on the surface of the building will minimise waste and it will feature low-level green walls. Landscaping will soften the effect of the building and add to interest at ground level.

Biological Support Building (University of Cambridge)

Biological Support Building (University of Cambridge)

Over the next few years, the facilities for research on the Biomedical Campus will be greatly increased as more organisations join.

Stem Cell Institute

Stem Cell Institute

The Stem Cell Institute is an international centre of excellence for research into stem cell biology and medicine. Scientists in the Institute collaborate to generate new knowledge and understanding of the biology of stem cells and provide the foundation for new medical treatments.

New Clinical Research Facility

New Clinical Research Facility

Over the next few years, the facilities for research on the Biomedical Campus will be greatly increased as more organisations join.

MedImmune in Cambridge

With over 550 employees, MedImmune’s team at Granta Park is focused on the research and early development of our biologics portfolio. MedImmune has built on the local legacy of Cambridge Antibody Technology (CAT) – acquired and integrated with us in 2007 – where three marketed products (Humira, Benlysta and raxibacumab) were invented. MedImmune Cambridge has strong collaborative links with numerous academics, researchers, foundations and neighbouring companies in the largest biotech cluster in Europe and has an active outreach programme within the local community.

Find out more

Working here

Our new Cambridge site is the result of a 500 million USD investment. It will be fully open in 2018 and bring together small molecule and biologics research and development activity across our main focus areas. The site will also be home to a wide range of leading scientific capabilities. Throughout, you’ll find an open, welcoming and vibrant culture where new discoveries can be made and new ideas pursued. 

Our scientists will work alongside over 12,000 healthcare professionals and researchers in one of Europe’s leading biotechnology cluster. We’ve also created unique partnerships here, with the Medical Research Council and Cancer Research UK – transformational collaborations that embrace the academic community while challenging our scientists on a daily basis. The result? An inspirational environment where science can thrive.

While our new R&D Centre and Corporate Headquarters are being built on the Cambridge Biomedical Campus, our 2,000 strong community of scientists and other professionals are based across interim sites in and around Cambridge. They work closely with the Cambridge community and with our global Biologics R&D arm, MedImmune, located in Cambridge for many years already.

 

Back to top